BenevolentAI benevolent.ai


Public list: Digital Health (6540) Unicorns - Billion Dollar Startups (363) Artificial Intelligence ( AI ) in Healthcare (478) Artificial Intelligence ( AI ) (4113) AI 100 (100) Healthcare Horizons (27) Clinical Trials Tech (201) Future of Pharma R&D (63)

BenevolentAI creates and applies AI and machine learning to update the way medicines are discovered and developed. Benevolent integrates its technology into every step of the drug discovery process from hypothesis generation to late-stage clinical development.

BenevolentAI creates and applies AI and machine learning to update the way medicines are discovered and developed. Benevolent integrates its technology into every step of the drug discovery process from hypothesis generation to late-stage clinical de...Show all

Company (Alive / Active)

Phone: +44 (0) 20 3096 0720

Fax:

40 Churchway

London, NW1 1LW
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BenevolentAI $345.6M Mar 17, 2020
GNS Healthcare $65.3M Apr 14, 2020
Numerate $19.5M Aug 7, 2019
See all 11 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BenevolentAI Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 11 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
New compounds i Dec 29, 2017 Sep 03, 2019 Patent
Crystalline compound as semicarbazide-sensitive amine oxidase (ssao) enzyme inhibitor Apr 22, 2016 Aug 06, 2019 Patent
Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (ssao) Apr 22, 2016 Jun 11, 2019 Patent
Compounds i Jul 17, 2019 Application
Orexin receptor antagonists May 10, 2018 Application
See all 8 patents